Abiopharma

Quad Recognized in 2026 Ad Age Agency Report and MM+M Agency 100

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes

LPL Financial Welcomes Daniel Zacharias to Decorum Wealth Management

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Wells Fargo Investment Institute: When Every Headline Shouts, Discipline Matters Most

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Duos Technologies Group Closes $55M Registered Direct Offering

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat